Idris Elba trademarks his name

Published: May 21, 2020, 21:19 IST | IANS | Los Angeles

Idris Elba has trademarked his name to launch beauty range with wife Sabrina

Actor Idris Elba has trademarked his name to launch beauty range with wife Sabrina. The actor has applied for permission to sell health and beauty products under his lifestyle brand Sable Labs and podcast Coupledom -- both of which he runs with wife, reports thesun.co.uk.

They submitted applications with the Intellectual Property Office earlier this year, under the name of his IE7 Holdings Limited. Through the company, he also runs a music business, clothing company and performing arts firm.

Their trademarks run across two classes with dozens of products in the list.

Under one, their products include soaps, aftershaves, cosmetics, make-up removers, mascara, lipstick, lip pencils and liners, eyebrow fixer, body powders, anti-wrinkle creams, bubble bath, bath gel, facial creams, skin-rejuvenation creams, skin soothing masks, sun care and sun-tanning preparations, and hair removal items.

The other list includes medicated preparations, serums, dermatological and pharmaceutical preparations for skin care, medicated acne preparations, nutritional supplements, body hydration, prevention and treatment of hair-loss, and treatment for the skin and the metabolism against the effects of fatigue or stress.

Along with trademarking the products, Elba has also applied in his own name to trademark the use of S'able Labs and Coupledom, stated the report.

All applications are pending and yet to be approved.

Catch up on all the latest entertainment news and gossip here. Also, download the new mid-day Android and iOS apps.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

Sign up for all the latest news, top galleries and trending videos from Mid-day.com

Subscribe
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK